ArticleCrohn's & colitis 3602025

Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naïve Patients With Early or Late Crohn's Disease: Results From the EVOLVE Expansion Study.

Britt Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.